About the Company
We do not have any company description for CERO THERAPEUTICS HOLDINGS, INC. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on CERO THERAPEUTICS HOLDINGS, INC.
CERo Therapeutics Holdings, Inc. Issues Additional Series D ... - Nasdaq
CERo Therapeutics Holdings, Inc. has announced the issuance of additional shares of its Series D Preferred Stock to institutional investors, following a previous agreement worth up to $8 million.
CERo Therapeutics Holdings, Inc. Announces $8 Million ... - Nasdaq
CERo Therapeutics Holdings, Inc. has announced a securities purchase agreement to raise up to $8 million through a convertible preferred stock offering. The initial $5 million is expected from an ...
CERo Therapeutics Holdings, Inc. Highlights Progress
SOUTH SAN FRANSCISCO, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (CERO), (“CERo” or the “Company”) an innovative immunotherapy company seeking to advance ...
CERo Therapeutics Holdings, Inc. Continues to Progress Toward Initial ...
About CERo Therapeutics Holdings, Inc. CERo is an innovative immunotherapy company advancing the development of next generation engineered T cell therapeutics for the treatment of cancer.
CERo Therapeutics Holdings, Inc. Presents Encouraging Preclinical Data ...
SOUTH SAN FRANSCISCO, Calif., March 13, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (CERO), (“CERo” or the “Company”) an innovative immunotherapy company seeking to advance ...
CERo Therapeutics Holdings, Inc. Doses First Patient with CER-1236 in ...
About CERo Therapeutics Holdings, Inc. CERo is an innovative immunotherapy company advancing the development of next generation engineered T cell therapeutics for the treatment of cancer.
CERo Therapeutics Holdings, Inc. Announces Initial Clinical Trial Site ...
SOUTH SAN FRANSCISCO, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (Nasdaq: CERO) (“CERo” or the “Company”) an innovative immunotherapy company seeking to ...
CERO | CERo Therapeutics Holdings Inc. Profile | MarketWatch
CERo Therapeutics Holdings Inc. 201 Haskins Way Suite 230 Oakland, California 94080 Phone1 215 731-9450 IndustryBiotechnology SectorHealth Care/Life Sciences Fiscal Year-end12/2025 RevenueN/A Net ...
CERo Therapeutics Holdings, Inc. Presents Encouraging Preclinical Data ...
About CERo Therapeutics Holdings, Inc. CERo is an innovative immunotherapy company advancing the development of next generation engineered T cell therapeutics for the treatment of cancer.
CERo Therapeutics Holdings, Inc. Highlights Progress
About CERo Therapeutics Holdings, Inc. CERo is an innovative immunotherapy company advancing the development of next generation engineered T cell therapeutics for the treatment of cancer.
Similar Companies
Loading the latest forecasts...